Diabetes Mellitus, Type 2: all 9,589 studies
Page 95 of 96. Open to participants first (1,332), then studies with results posted, then the rest; newest registration first within each.
- Opposing Step-by-step Insulin Reinforcement to Intensified StrategyCompletedNCT00174642Phase 3
- Effects of Exercise Training on Left Ventricular Function in Type 2 Diabetic Patients Post Coronary Artery Bypass GraftCompletedNCT00172536Not applicable
- Contraction (Exercise) Mediated Glucose Uptake as a Therapeutic Target in Type 2 DiabetesCompletedNCT00168519Not applicable
- Metabolic Effects of AlcoholCompletedNCT00167115Not applicable
- Effects of a Mediterranean Style Diet on Vascular Health in Type 2 DiabetesCompletedNCT00163683Not applicable
- Post-PCI:Cardiac Imaging in Patients With Diabetes to Detect Coronary Artery Blockages Previously Opened by AngioplastyCompletedNCT00162357Phase 4
- A Phase IIA Study of BMS-512148 to Assess Safety, Exposure, and Biological Effects in Stable Type 2 Diabetic SubjectsCompletedNCT00162305Phase 2
- Effectiveness and Cost-effectiveness of the Diabetes Integrated Care Breakthrough CollaborativeCompletedNCT00160017
- Abdominal Adipose Tissue Distribution in Type 2 Diabetic Patients Treated During 6 Months With Pioglitazone or InsulinTerminatedNCT00159211Not applicable
- MATCHED (MC-1 and ACE Therapeutic Combination for Hypertensive Diabetics)CompletedNCT00157729Phase 2
- Delapril and Manidipine for Nephroprotection in Diabetes (DEMAND)CompletedNCT00157586Phase 3
- Renal and Systemic Effects of NCX4016 in Patients With Type 2 Diabetes and Early NephropathyTerminatedNCT00157508Phase 2
- Ezetimibe and Simvastatin in Dyslipidemia of DiabetesCompletedNCT00157482Phase 2
- Efficacy and Safety of ATL-962 in Obese DiabeticsCompletedNCT00156897Phase 2
- The Gene Expression Patterns in the Peripheral White Blood Cells of Type 2 Diabetic PatientsStatus unknownNCT00155922
- Effect of Liraglutide on Blood Glucose Control in Japanese Subjects With Type 2 DiabetesCompletedNCT00154414Phase 2
- Effect of Liraglutide on Blood Glucose Control in Subjects With Type 2 DiabetesCompletedNCT00154401Phase 2
- Long-Term Study of Safety and Efficacy of WelChol® as an Additional Therapy in Patients With Type 2 DiabetesCompletedNCT00151762Phase 3
- WelChol® and Insulin in Treating Patients With Type 2 DiabetesCompletedNCT00151749Phase 3
- LANN-study: Lantus, Amaryl, Novorapid, Novomix StudyCompletedNCT00151697Phase 3
- Stepping Up to Health: Feedback to Promote Physical Activity in DiabetesCompletedNCT00151021Not applicable
- Evaluation of the Effects of Different Interventions on Glycemic Control in Newly-Diagnosed Type 2 Diabetic PatientsCompletedNCT00147836Not applicable
- WelChol® and Sulfonylurea in Treating Patients With Type 2 DiabetesCompletedNCT00147758Phase 3
- WelChol® With Metformin in Treating Patients With Type 2 DiabetesCompletedNCT00147719Phase 3
- Blood Pressure and Glucose Lowering for the Prevention of Vascular Disease in High Risk Patients With Type 2 DiabetesCompletedNCT00145925Phase 3
- Prospective Study of Patients With HirsutismStatus unknownNCT00145288
- Effects of Chromium Supplementation on Parameters of the Metabolic Syndrome in Patients With Type 2 Diabetes MellitusCompletedNCT00145093Phase 3
- A Study on Ca Blocker Versus AII Antagonists in Hypertension With Type 2 DiabetesStatus unknownNCT00144144Phase 4
- Placebo and Active Controlled Study of Rivoglitazone in Type 2 DiabetesCompletedNCT00143520Phase 2/3
- To Examine the Lung When People With Diabetes Take an Inhaled Form of Insulin, Compared to Subcutaneous Insulin.CompletedNCT00143338Phase 2
- Gene Expression Profiling and Bioinformatic Analysis Identifying Genes and Biochemical Pathways in Type 2 DiabetesStatus unknownNCT00143013
- Enhancing Support for Women at Risk for Heart DiseaseCompletedNCT00142701Not applicable
- Efficacy and Safety of Androgel in the Treatment of Hypogonadal and Low Testosterone Men With Type 2 DiabetesCompletedNCT00141492Phase 2
- Evaluating Atorvastatin With Omega-3 Fatty Acids in Cardiovascular Risk Reduction in Patients With Type 2 DiabetesCompletedNCT00141232Phase 4
- US Inhaled Insulin Therapeutic Choice Questionnaire StudyCompletedNCT00139763Phase 3
- Extension to a Study on the Efficacy and Safety of Vildagliptin Compared to Rosiglitazone in Drug Naive Patients With Type 2 DiabetesCompletedNCT00138619Phase 3
- Extension to a Study on the Efficacy and Safety of Vildagliptin in Combination With Insulin in Patients With Type 2 DiabetesCompletedNCT00138606Phase 3
- Extension to a Study of the Efficacy and Safety of Vildagliptin in Patients With Type 2 Diabetes With Hemoglobin A1c (HbA1c) 9-11%CompletedNCT00138593Phase 3
- Extension to a Study on the Efficacy and Safety of Vildagliptin in Combination With Glimepiride in Patients With Type 2 DiabetesCompletedNCT00138580Phase 3
- Extension to a Study on the Efficacy and Safety of Vildagliptin Compared to Metformin in Drug Naive Patients With Type 2 DiabetesCompletedNCT00138567Phase 3
- Extension to a Study on the Efficacy and Safety of Vildagliptin in Combination With Pioglitazone in Patients With Type 2 DiabetesCompletedNCT00138554Phase 3
- Extension to a Study to Assess the Efficacy and Safety of Three Doses of Vildagliptin in Patients With Type 2 DiabetesCompletedNCT00138541Phase 3
- Extension to a Study on the Efficacy and Safety of Vildagliptin in Combination With Metformin in Patients With Type 2 DiabetesCompletedNCT00138515Phase 3
- Effects of Amlodipine/Benazepril on Albuminuria in Hypertensive Patients With Type 2 Diabetes MellitusCompletedNCT00136773Phase 4
- Insulin Glulisine Administered Pre-meal Versus Post-meal in Adult Subjects With Type 2 Diabetes Mellitus Receiving Insulin Glargine as Basal InsulinCompletedNCT00135096Phase 3
- Variable Bolus Regimen 1-2-3 for Type 2 Diabetes MellitusCompletedNCT00135083Phase 3
- Hospital In-Patient Insulin StudyTerminatedNCT00135070Phase 4
- Insulin Glulisine in Adult Subjects With Type 2 Diabetes Receiving Insulin Glargine as Basal InsulinCompletedNCT00135057Phase 3
- A 2 Year Trial of Patients With Type 2 Diabetes Focusing on Cardiovascular Diagnostics and Metabolic ControlCompletedNCT00133718Phase 4
- The Supplementary Effects of the Extract of Agaricus Blazei Murril on Type II Diabetes Mellitus (DM)CompletedNCT00131287Phase 3
- An Investigational Drug Co-Administered With Insulin in Patients With Type 2 Diabetes (0478-065)TerminatedNCT00130806Phase 3
- Pediatric Atorvastatin in Diabetes Intervention Trial (PADIT)CompletedNCT00130481Not applicable
- Comparison of Valsartan With Amlodipine in Hypertensive Patients With Glucose IntoleranceCompletedNCT00129233Phase 4
- The Heat Study: 2 Year Lifestyle Intervention in Overweight Women to Encourage Weight ManagementCompletedNCT00128336Phase 3
- Trial of New Dietary Treatment of DiabetesTerminatedNCT00128089Phase 1
- Reliability of Dosing With NovoLog® Mix 70/30 FlexPen® Compared With Vial and SyringeCompletedNCT00127296Phase 1
- LOADD (Lifestyle Over and Above Drugs in Diabetes) StudyStatus unknownNCT00124553Not applicable
- Atorvastatin and Endothelial Function in Type 2 Diabetes Mellitus (ATTEND-Study)CompletedNCT00124397Phase 4
- Rosiglitazone Plaque StudyStatus unknownNCT00123227Phase 3
- South Danish Diabetes Study: Evaluation of the Antidiabetic Treatment of Type 2 Diabetes MellitusCompletedNCT00121966Phase 4
- Efficacy and Safety of Three Doses of Vildagliptin in Drug Naive Patients With Type 2 DiabetesCompletedNCT00120536Phase 3
- An Online System to Improve Diabetes Self-CareCompletedNCT00119938Not applicable
- Effect of Repaglinide Versus Metformin Treatment in Non-Obese Patients With Type-2-DiabetesCompletedNCT00118963Phase 4
- Effect of Metformin Versus Repaglinide Treatment in Non-Obese Type 2 Diabetic Patients Uncontrolled by DietCompletedNCT00118950Phase 4
- Exercise Training for Patients With Poor Leg CirculationCompletedNCT00118560Not applicable
- A Study of the Treatment of Type 2 Diabetes With an Insulin Infusion PumpCompletedNCT00115973Phase 1
- A Study of DPP-IV Inhibitor in Patients With Type 2 DiabetesCompletedNCT00111670Phase 2
- A Study of DPP-IV Inhibitor in Patients With Type 2 DiabetesCompletedNCT00111631Phase 2
- Study to Examine the Effect on Glucose Control and Safety/Tolerability of Exenatide Given Two Times a Day to Subjects With Type 2 DiabetesCompletedNCT00111540Phase 3
- Effects of PN2034 in Insulin-Dependent Patients With Type 2 DiabetesCompletedNCT00110864Phase 2
- Safety and Efficacy Study of PN2034 in Type 2 Diabetes Patients on Concomitant Rosiglitazone and Metformin (or Avandamet)CompletedNCT00110851Phase 2
- Japanese Primary Prevention of Atherosclerosis With Aspirin for Diabetes (JPAD) TrialCompletedNCT00110448Phase 4
- A Multicenter Study to Evaluate the Cholesterol Lowering Effects of Two Marketed Products in Patients With Type 2 Diabetes Mellitus and Hypercholesterolemia (MK-0653A-077)CompletedNCT00110435Phase 3
- Comparing Pre-Mixed Insulin With Insulin Glargine Combined With Rapid-Acting Insulin in Patients With Type 2 DiabetesCompletedNCT00110370Phase 4
- Efficacy and Safety of Vildagliptin Compared to Acarbose in Drug Naive Patients With Type 2 DiabetesCompletedNCT00110240Phase 3
- Evaluation of Diabetes Self-Management Consultant CareCompletedNCT00109720Not applicable
- Improving Diabetes in Primary Care (IMPACT)CompletedNCT00108927
- Low Carbohydrate Diet Compared to Calorie and Fat Restricted Diet in Patients With Obesity and Type II DiabetesCompletedNCT00108459Phase 3
- Effect of a High Protein Diet on the 24-hour Profile of Ghrelin, GH (Growth Hormone) and IGF-1 (Insulin-like Growth Factor-1)CompletedNCT00108225Not applicable
- Clinical Utility and Safety of Pramlintide in Subjects With Type 1 and Type 2 Diabetes MellitusCompletedNCT00108004Phase 3
- Study of Muraglitazar Versus Pioglitazone in Type 2 DiabetesCompletedNCT00106808Phase 3
- Comparison of Insulin Detemir With Insulin Glargine in Type 2 DiabetesCompletedNCT00106366Phase 3
- Vildagliptin Compared to Glimepiride in Combination With Metformin in Patients With Type 2 DiabetesCompletedNCT00106340Phase 3
- Comparison of Insulin Detemir Morning, Insulin Detemir Evening and NPH Insulin Evening in Patients With Type 2 DiabetesCompletedNCT00104182Phase 3
- Study Examining Exenatide Long-Acting Release in Subjects With Type 2 DiabetesCompletedNCT00103935Phase 2
- Vildagliptin Compared to Gliclazide in Combination With Metformin in Patients With Type 2 DiabetesCompletedNCT00102466Phase 3
- Efficacy and Safety of Vildagliptin Compared to Gliclazide in Drug Naive Patients With Type 2 DiabetesCompletedNCT00102388Phase 3
- Study of the Safety of FG-3019 in Incipient Nephropathy Due to Type 1 or Type 2 Diabetes MellitusCompletedNCT00102297Phase 1
- Efficacy and Safety of Vildagliptin in Combination With Pioglitazone in Drug Naive Patients With Type 2 DiabetesCompletedNCT00101803Phase 3
- INITIATE Plus (INITiation of Insulin to Reach A1c TargEt) StudyCompletedNCT00101751Phase 4
- Efficacy and Safety of Vildagliptin Compared to Placebo in Patients With Type 2 Diabetes and Mild HyperglycemiaCompletedNCT00101712Phase 3
- Efficacy and Safety of Vildagliptin in Patients With Type 2 Diabetes With HbA1c 9-11%CompletedNCT00101673Phase 3
- A Clinical Study to Assess the Effect of Vildagliptin on Postprandial Lipid Parameters in Patients With Type 2 DiabetesCompletedNCT00099957Phase 2
- Efficacy and Safety of Vildagliptin in Combination With Glimepiride in Patients With Type 2 DiabetesCompletedNCT00099944Phase 3
- Efficacy and Safety of Vildagliptin in Combination With Insulin in Patients With Type 2 DiabetesCompletedNCT00099931Phase 3
- Efficacy and Safety of Vildagliptin Compared to Rosiglitazone in Drug Naive Patients With Type 2 DiabetesCompletedNCT00099918Phase 3
- A Clinical Study to Assess the Efficacy and Safety of Three Doses of Vildagliptin in Patients With Type 2 DiabetesCompletedNCT00099905Phase 3
- Efficacy and Safety of Vildagliptin in Combination With Metformin in Patients With Type 2 DiabetesCompletedNCT00099892Phase 3
- Efficacy and Safety of Vildagliptin Compared to Metformin in Drug Naive Patients With Type 2 DiabetesCompletedNCT00099866Phase 3
- Efficacy and Safety of Vildagliptin in Combination With Pioglitazone in Patients With Type 2 DiabetesCompletedNCT00099853Phase 3